Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Best injection spot for a 3D-guided inferior alveolar nerve block device

Official title: The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD): A Randomized Control Trial

Run by Boston University · NCT06676098 · Data updated 2026-11-12

This trial tests whether a CBCT-based 3D-guided device can place inferior alveolar nerve block injections more accurately for patients needing root canal treatment on lower molars or premolars.

More Inferior Alveolar Nerve Block trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorBoston University
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedDecember 17, 2025
Main results expectedNovember 2027
Study endsNovember 2027
Registry record updatedJanuary 27, 2026
Trial IDNCT06676098 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults treated at Boston University's Goldman School of Dental Medicine who are ASA I, need non-surgical endodontic therapy on a mandibular molar or premolar, have an asymptomatic pulpal diagnosis, a quadrant with at least three vital teeth, will receive a clinically indicated CBCT, and agree to guided IANB are ideal candidates.

Probably not a fit

Patients who are pregnant, allergic to lidocaine, articaine, or resin, have prior jaw surgery, have teeth unresponsive to thermal testing, or cannot/decline to have a CBCT or guided injection are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Mandibular teeth often require an inferior alveolar nerve block (IANB), but traditional landmark-based IANB is a blind technique with reported failure rates up to 30–45%. This interventional protocol uses a cone beam CT (CBCT)-guided, patient-specific 3D device (IANBD) to direct the needle toward the mandibular foramen. Eligible patients will receive a clinically indicated CBCT and a guided IANB using the 3D device, with outcomes focused on first-attempt anesthesia success, tissue impact, and patient discomfort. The work is conducted at Boston University's Goldman School of Dental Medicine.

Why it matters

Potential benefit: If successful, patients could achieve reliable anesthesia on the first injection with fewer needle passes, less tissue trauma, and reduced injection-related discomfort.

How similar studies have gone: Image-guided mandibular anesthesia approaches using CBCT and navigation have shown improved needle placement accuracy in prior reports, but this specific 3D-guided IANBD device is a relatively novel investigational application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient of Henry M. Goldman School of Dentistry (GSDM)
* Medical History indicating American Society of Anesthesiology (ASA)1
* Need Non-surgical Endodontic Therapy on Mandibular Molar or Premolar
* Asymptomatic pulpal diagnosis (normal, necrotic, asymptomatic irreversible pulpitis, retreatment with no symptoms)
* The quadrant to be treated must have at least 3 vital teeth.
* Going to receive a CBCT required for clinical purposes
* Must be willing to receive guided IANB

Exclusion Criteria:

* Allergy to lidocaine or articaine
* Resin allergy
* Normal teeth unresponsive to thermal testing (ie calcified chamber)
* Prior jaw surgery
* Currently pregnant

Where it's running

  • Goldman School of Dental Medicine, Boston University
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Tum-Yi Hsu, DMD DScD — BU Goldman School of Dental Medicine, Endodontics
  • Study coordinator: Tum-Yi Hsu, DMD DScD
  • Email: thsu@bu.edu
  • Phone: (617) 358-3481

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.